HAE: Learn about it, Talk about it – Shire
Hereditary angioedema (HAE) is a rare, genetic and
potentially life-threatening swelling condition which
is frequently misdiagnosed because the symptoms
can be non-specific and often mimic other
conditions. In addition, many HCPs are not familiar
with the condition or how to differentiate it from
other types of angioedema, due in part to its rare
nature. In response, the HAE: Learn About It, Talk
About It clinician education program was developed
to educate and increase awareness about HAE
among the various specialists who may see patients
with the condition. Ultimately, the program hopes to
decrease time to diagnosis and advance patient care.
IMS Health and Purdue Pharma L.P.
Purdue Pharma L.P. wanted to understand how
local, emerging stakeholders (e.g., integrated delivery
networks) are affecting their major therapeutic area.
They wanted to become a preferred, value-focused
industry partner to the largest, most influential
IDNs to improve quality and patient satisfaction. By
using an integrated database with metrics that create
a local, stakeholder-based framework, IMS Health
helped them identify high-influence, high-volume
IDNs within a specific therapeutic area. This led
to the activation of a comprehensive IDN strategy,
including alignment of brand value propositions
to stakeholders and the development of job
descriptions for a new set of KAMs that would call on these high-influence, high-volume IDNs.
JointMan Clinical Population Health Tool –
Discus Analytics (DA) is addressing the lack
of actionable industry data & legislation that
is compelling practices to adopt healthcare
informatics that were previously unavailable.
The JointMan Clinical Population Health Tool
will reduce overall treatment costs, minimize the
number of unnecessary treatments, and improve
the quality of life for patients, as well as transform
practices with a clinical intelligence platform
and seamlessly support clinical decisions that are
aligned with best practices in the care process.
Ensuring that patients and physicians are active
participants in all elements, new knowledge is captured in real-time as an integral by-product of the care experience
and research intelligence of the future.